Oliver Langer

Has grant

Associate Professor

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

PETABC

Open Date: 2021-01-01

Close Date: 2024-01-01

Grant: Close

Efffect of antihypertensive drugs on pulmonary ACE2

Open Date: 2020-10-01

Close Date: 2024-03-31

Grant: Close

PET/MR imaging to assess the role of membrane transporters in pulmonary disposition of inhaled drugs

Open Date: 2019-01-01

Close Date: 2021-01-01

Grant: Close

Impact of ABCB1 on neuro-PK of metoclopramide

Open Date: 2018-04-01

Close Date: 2021-03-31

Grant: Close

Improving brain distribution of drugs targeted to the brain

Open Date: 2016-01-01

Close Date: 2019-01-01

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (8)

Martin Bauer

Medical University of Vienna

AUSTRIA

View details

Severin Mairinger

Medical University of Vienna

AUSTRIA

View details

Nicolas Tournier

Université Paris-Saclay

FRANCE

View details

Thomas Stimpfl

Medical University of Vienna

AUSTRIA

View details

Thomas Pekar

Head of Department

Fachhochschule Wiener Neustadt

AUSTRIA

View details

Thomas Wanek

Medical University of Vienna

AUSTRIA

View details

Claudia Kuntner

Assistant Professor

Medical University of Vienna

AUSTRIA

View details

Joseph DiMasi

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Oliver Langer

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Effect of budesonide on pulmonary activity of multidrug resistance-associated protein 1 assessed with PET imaging in rats

Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice

Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats

Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [<sup>11</sup>C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier

Strategic, feasibility, economic, and cultural aspects of phase 0 approaches: Is it time to change the drug development process in order to increase productivity?

Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats.

Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin.

Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice?

PET imaging to assess the impact of P-glycoprotein on pulmonary drug delivery in rats.

Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling

Collaborators (8)

Martin Bauer

Severin Mairinger

Nicolas Tournier

Thomas Stimpfl

Thomas Pekar

Thomas Wanek

Claudia Kuntner

Joseph DiMasi

Make your next move.